Community Pharmacists’ Attitude, Practice and Confidence in Supporting People with Diabetes in Japan and Ireland: A Cross-sectional Survey-Reference-Cited by-同舟云学术

Community Pharmacists’ Attitude, Practice and Confidence in Supporting People with Diabetes in Japan and Ireland: A Cross-sectional Survey

Published:2023-10-01 Issue:10 Volume:143 Page:871-879
ISSN:0031-6903
Container-title:YAKUGAKU ZASSHI
language:en
Short-container-title:YAKUGAKU ZASSHI

Author:

Mittal Swati¹,Okada Hiroshi¹,Bermingham Margaret²,Onda Mitsuko³,Farrelly Sarah²,Zaki Marian²,Nakayama Takeo¹

Affiliation:

1. Department of Health Informatics, Graduate School of Medicine & School of Public Health, Kyoto University

2. Pharmaceutical Care Research Group, School of Pharmacy, University College Cork

3. Department of Social and Administrative Pharmacy, Osaka University of Medical and Pharmaceutical Sciences

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/yakushi/143/10/143_23-00064/_pdf

Reference28 articles.

1. 1) Statista. “Diabetes—Statistics & Facts.”: 〈https://www.statista.com/topics/1723/diabetes/#topicOverview〉, cited 8 May, 2023.

2. 2) The World Bank, International Diabetes Federation, Diabetes Atlas. “Diabetes prevalence (% of population ages 20 to 79).”: 〈https://data.worldbank.org/indicator/SH.STA.DIAB.ZS?end=2021&start=2000&view=chart〉, cited 8 May, 2023.

3. 3) The World Bank, International Diabetes Federation, Diabetes Atlas. “Diabetes prevalence (% of population ages 20 to 79)-Japan.”: 〈https://data.worldbank.org/indicator/SH.STA.DIAB.ZS?locations=JP〉, cited 8 May, 2023.

4. 4) Index Mundi. “Diabetes prevalence (% of population ages 20 to 79).”: 〈https://www.indexmundi.com/facts/indicators/SH.STA.DIAB.ZS/compare?country=ie〉, cited 8 May, 2023.

5. 5) World Health Organization. ”WHO Technical Report Series, No. 961, 2011. Annex 8, Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services.”: 〈https://www.who.int/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex8-fipwhoguidelinesgoodpharmacypractice.pdf〉, cited 25 March, 2023.